Market due diligence on the pathology industry in Malaysia and Singapore

Summary

Key question: “What are the market prospects and competitive landscape of the pathology industry in Malaysia and Singapore, and how do they impact our strategic market entry options?”

Situation

Our client was exploring a strategic entry into the diagnostics market in Malaysia and Singapore, and wanted to understand the market prospects, competitive dynamics and potential routes to market.  

We conducted a market assessment on pathology services and proposed several market entry routes for consideration. 

Approach
  • Discussed key trends in the pathology industry in Malaysia and Singapore
  • Market sizing of the diagnostics industry, and future growth opportunities ie new services
  • Detailed customer survey on the ground and interviews with key users including hospitals, doctors, clinicians, patients, etc
  • Assessed key purchasing factors for pathology services
  • Detailed analysis on competitors - of top 10 players by market share (revenues, and by key services provided)
  • Identified key payors in the market i.e.corporate funders, insurance companies and patients 
Impact
  • Based on primary and secondary sources, triangulated the market size and potential growth of pathology services in Malaysia and Singapore
  • Conducted detailed analysis of the competitive landscape in Malaysia and Singapore 
  • Provided recommendations on potential strategic market entry routes into Malaysia and Singapore
Market size of the pathology industry
Market share of key players in the industry
Hide

Required fields are marked with an asterisk(*)

By submitting your email address, you acknowledge that you have read the Privacy Statement and that you consent to our processing data in accordance with the Privacy Statement (including international transfers). If you change your mind at any time about wishing to receive the information from us, you can send us an email message using the Contact Us page.

Contact us

Yennie Tan

Yennie Tan

Deals Partner Deals Strategy & Operations, and Healthcare Leader, PwC Malaysia

Tel: +60 (3) 2173 0551

Yen Li Cheong

Yen Li Cheong

Deals Director, Deals Strategy, PwC Malaysia

Tel: +60 (3) 2173 0299